000294661 001__ 294661
000294661 005__ 20241125182701.0
000294661 0247_ $$2doi$$a10.1007/s00432-024-06019-3
000294661 0247_ $$2pmid$$apmid:39516427
000294661 0247_ $$2pmc$$apmc:PMC11549193
000294661 0247_ $$2ISSN$$a0301-1585
000294661 0247_ $$2ISSN$$a0084-5353
000294661 0247_ $$2ISSN$$a0171-5216
000294661 0247_ $$2ISSN$$a1432-1335
000294661 037__ $$aDKFZ-2024-02396
000294661 041__ $$aEnglish
000294661 082__ $$a610
000294661 1001_ $$aErdmann, Friederike$$b0
000294661 245__ $$aImpact of the COVID-19 pandemic on cancer diagnoses, oncological care and cancer patients in Germany: a report from the 'COVID & Cancer' workshop 2023 of the German Society for Epidemiology (DGEpi).
000294661 260__ $$aHeidelberg$$bSpringer$$c2024
000294661 3367_ $$2DRIVER$$aarticle
000294661 3367_ $$2DataCite$$aOutput Types/Journal article
000294661 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1732535311_8025
000294661 3367_ $$2BibTeX$$aARTICLE
000294661 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000294661 3367_ $$00$$2EndNote$$aJournal Article
000294661 500__ $$a#LA:C071#LA:M110#
000294661 520__ $$aThe COVID-19 pandemic was associated with severe disruptions in healthcare worldwide. Cancer patients are at particular risk of adverse consequences from delays in diagnosis and treatment. To evaluate the available data on the impact of the pandemic on cancer diagnoses, oncological care and patient well-being in Germany, the German Society for Epidemiology (DGEpi) in collaboration with the Epidemiological Cancer Registry of Lower Saxony invited to a workshop on 'COVID & Cancer' (held on 26-27 October 2023 in Hanover, Germany). This report provides a summary of the scientific presentations, highlights methodological challenges, and recognises essential evidence gaps.Twelve studies addressing various aspects in relation to cancer diagnoses, oncological care and patient well-being during the COVID-19 pandemic in Germany and two talks sharing experiences from the UK and the Netherlands were presented at the workshop.Results from German cancer registries consistently showed lower number of incident cancer diagnoses among adults during the first months of the pandemic compared to the respective months of the years before the pandemic. Data from the cancer registries of Baden-Württemberg and Lower Saxony found especially for breast cancer a notable drop (by approximately one third) in the numbers of diagnoses during the first restriction period (April-May 2020), during which the nationwide mammography screening programme in Germany was temporarily suspended. Overall, the extent and ways, in which the pandemic had adversely affected cancer diagnoses, oncological care and created service backlogs, is still not adequately understood. The long-term consequences are yet to be determined.
000294661 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000294661 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000294661 650_7 $$2Other$$aAdverse consequences
000294661 650_7 $$2Other$$aCOVID-19 pandemic
000294661 650_7 $$2Other$$aCancer care
000294661 650_7 $$2Other$$aDelayed diagnosis
000294661 650_7 $$2Other$$aGermany
000294661 650_7 $$2Other$$aIncidence
000294661 650_2 $$2MeSH$$aHumans
000294661 650_2 $$2MeSH$$aCOVID-19: epidemiology
000294661 650_2 $$2MeSH$$aGermany: epidemiology
000294661 650_2 $$2MeSH$$aNeoplasms: epidemiology
000294661 650_2 $$2MeSH$$aNeoplasms: diagnosis
000294661 650_2 $$2MeSH$$aNeoplasms: therapy
000294661 650_2 $$2MeSH$$aRegistries
000294661 650_2 $$2MeSH$$aSARS-CoV-2
000294661 650_2 $$2MeSH$$aMedical Oncology: methods
000294661 650_2 $$2MeSH$$aPandemics
000294661 650_2 $$2MeSH$$aFemale
000294661 7001_ $$aWellbrock, Maike$$b1
000294661 7001_ $$aDe Santis, Karina Karolina$$b2
000294661 7001_ $$aHübner, Joachim$$b3
000294661 7001_ $$aVoigtländer, Sven$$b4
000294661 7001_ $$0P:(DE-He78)d023fdf423d87ee6c710e34dd7581fa0$$aArndt, Volker$$b5$$eLast author$$udkfz
000294661 773__ $$0PERI:(DE-600)1459285-X$$a10.1007/s00432-024-06019-3$$gVol. 150, no. 11, p. 491$$n11$$p491$$tJournal of cancer research and clinical oncology$$v150$$x0301-1585$$y2024
000294661 909CO $$ooai:inrepo02.dkfz.de:294661$$pVDB
000294661 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)d023fdf423d87ee6c710e34dd7581fa0$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000294661 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000294661 9141_ $$y2024
000294661 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2023-10-21$$wger
000294661 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2023-10-21$$wger
000294661 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-21
000294661 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-21
000294661 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-10-21
000294661 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-10-21
000294661 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-21
000294661 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2023-10-21
000294661 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2023-10-21
000294661 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-10-21
000294661 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-21
000294661 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ CANCER RES CLIN : 2022$$d2023-10-21
000294661 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2023-10-21
000294661 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2023-10-21
000294661 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2023-10-21
000294661 9202_ $$0I:(DE-He78)C071-20160331$$kC071$$lC071 Cancer Survivorship$$x0
000294661 9202_ $$0I:(DE-He78)M110-20160331$$kM110$$lM110 Epidemiologisches Krebsregister BW$$x1
000294661 9201_ $$0I:(DE-He78)C071-20160331$$kC071$$lC071 Cancer Survivorship$$x0
000294661 9201_ $$0I:(DE-He78)M110-20160331$$kM110$$lM110 Epidemiologisches Krebsregister BW$$x1
000294661 980__ $$ajournal
000294661 980__ $$aVDB
000294661 980__ $$aI:(DE-He78)C071-20160331
000294661 980__ $$aI:(DE-He78)M110-20160331
000294661 980__ $$aUNRESTRICTED